Fingerprint
Dive into the research topics of 'Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
Research output: Contribution to journal › Comment/debate › peer-review
5
Scopus
citations